Standard
Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab. / Fabbri, Alice; O'Keeffe, Mary; Moynihan, Ray; Mollebaek, Mathias; Mohammad, Annim; Bhasale, Alice; Puil, Lorri; Mintzes, Barbara.
In:
British Journal of Clinical Pharmacology, Vol. 86, No. 7, 2020, p. 1416-1429.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Fabbri, A, O'Keeffe, M, Moynihan, R
, Mollebaek, M, Mohammad, A, Bhasale, A, Puil, L & Mintzes, B 2020, '
Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab',
British Journal of Clinical Pharmacology, vol. 86, no. 7, pp. 1416-1429.
https://doi.org/10.1111/bcp.14255APA
Fabbri, A., O'Keeffe, M., Moynihan, R.
, Mollebaek, M., Mohammad, A., Bhasale, A., Puil, L., & Mintzes, B. (2020).
Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab.
British Journal of Clinical Pharmacology,
86(7), 1416-1429.
https://doi.org/10.1111/bcp.14255Vancouver
Fabbri A, O'Keeffe M, Moynihan R
, Mollebaek M, Mohammad A, Bhasale A et al.
Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab.
British Journal of Clinical Pharmacology. 2020;86(7):1416-1429.
https://doi.org/10.1111/bcp.14255Author
Fabbri, Alice ; O'Keeffe, Mary ; Moynihan, Ray ; Mollebaek, Mathias ; Mohammad, Annim ; Bhasale, Alice ; Puil, Lorri ; Mintzes, Barbara. / Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab. In: British Journal of Clinical Pharmacology. 2020 ; Vol. 86, No. 7. pp. 1416-1429.
Bibtex
@article{5e0c564e325f4244859463ad6e627f3f,
title = "Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab",
keywords = "clinical pharmacology, drug information, medication safety, public health",
author = "Alice Fabbri and Mary O'Keeffe and Ray Moynihan and Mathias Mollebaek and Annim Mohammad and Alice Bhasale and Lorri Puil and Barbara Mintzes",
year = "2020",
doi = "10.1111/bcp.14255",
language = "English",
volume = "86",
pages = "1416--1429",
journal = "British Journal of Clinical Pharmacology, Supplement",
issn = "0264-3774",
publisher = "Wiley-Blackwell",
number = "7",
}
RIS
TY - JOUR
T1 - Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab
AU - Fabbri, Alice
AU - O'Keeffe, Mary
AU - Moynihan, Ray
AU - Mollebaek, Mathias
AU - Mohammad, Annim
AU - Bhasale, Alice
AU - Puil, Lorri
AU - Mintzes, Barbara
PY - 2020
Y1 - 2020
KW - clinical pharmacology
KW - drug information
KW - medication safety
KW - public health
U2 - 10.1111/bcp.14255
DO - 10.1111/bcp.14255
M3 - Journal article
C2 - 32067255
VL - 86
SP - 1416
EP - 1429
JO - British Journal of Clinical Pharmacology, Supplement
JF - British Journal of Clinical Pharmacology, Supplement
SN - 0264-3774
IS - 7
ER -
